Novartis secures pair of regulatory wins for skin disease and malaria treatments
Novartis’ Rhapsido has won approval in Europe, while Coartem Baby has received WHO prequalification.
Drug Development
Sun Pharma to acquire Organon for $11.75bn
OZMOSI and Planview partner to enhance pharmaceutical data integration
Cumberland to sell drug portfolio to Apotex for $100m
Sanofi receives FDA approval for Tzield in paediatric diabetes
MSD teams up with Google Cloud on agentic AI transformation
BioAegis and Prenosis partner for inflammatory disease therapies
Health Canada approves Biocon’s two denosumab biosimilars
